These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9501275)

  • 41. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.
    Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C
    J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and properties of phosphomannomutase from baker's yeast.
    GLASER L; KORNFELD S; BROWN DH
    Biochim Biophys Acta; 1959 Jun; 33(2):522-6. PubMed ID: 13670924
    [No Abstract]   [Full Text] [Related]  

  • 43. Carbohydrate-deficient glycoprotein syndrome type 1 with profound thrombocytopenia and normal phosphomannomutase and phosphomannose isomerase activities.
    Acarregui MJ; George TN; Rhead WJ
    J Pediatr; 1998 Nov; 133(5):697-700. PubMed ID: 9821433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Skin manifestations of protein glycosylation deficiency, the CDG (carbohydrate deficient glycoprotein) type 1 syndrome].
    Vabres P; Sevin C; Amoric JC; Odièvre MH; Saudubray JM; de Prost Y
    Ann Dermatol Venereol; 1998 Oct; 125(10):715-6. PubMed ID: 9835963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation of the human phosphomannomutase gene (PMM1) and assignment to chromosome 22q13.
    Wada Y; Sakamoto M
    Genomics; 1997 Feb; 39(3):416-7. PubMed ID: 9119384
    [No Abstract]   [Full Text] [Related]  

  • 46. Prenatal diagnosis for CDG Ia based on post-mortem molecular study of Guthrie card.
    Nogueira C; Quelhas D; Vilarinho L
    Mol Genet Metab; 2006 Apr; 87(4):379. PubMed ID: 16343971
    [No Abstract]   [Full Text] [Related]  

  • 47. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
    Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
    Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2.
    Pirard M; Matthijs G; Heykants L; Schollen E; Grünewald S; Jaeken J; van Schaftingen E
    FEBS Lett; 1999 Jun; 452(3):319-22. PubMed ID: 10386614
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection.
    Orvisky E; Stubblefield B; Long RT; Martin BM; Sidransky E; Krasnewich D
    Anal Biochem; 2003 Jun; 317(1):12-8. PubMed ID: 12729595
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atrial septal defect in a patient with congenital disorder of glycosylation type 1a: a case report.
    Wu RH; Li DF; Tang WT; Qiu KY; Li Y; Liao XY; Tang DX; Qin LJ; Deng BQ; Luo XY
    J Med Case Rep; 2018 Jan; 12(1):17. PubMed ID: 29361989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.
    Parkinson WM; Dookwah M; Dear ML; Gatto CL; Aoki K; Tiemeyer M; Broadie K
    Dis Model Mech; 2016 May; 9(5):513-27. PubMed ID: 26940433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
    Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
    J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
    [No Abstract]   [Full Text] [Related]  

  • 54. Prenatal diagnosis in CDG1 families: beware of heterogeneity.
    Matthijs G; Schollen E; Cassiman JJ; Cormier-Daire V; Jaeken J; van Schaftingen E
    Eur J Hum Genet; 1998; 6(2):99-104. PubMed ID: 9781052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carbohydrate-deficient glycoprotein (CDG) syndrome (Jaeken syndrome)].
    Ohno K
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):474-9. PubMed ID: 9645114
    [No Abstract]   [Full Text] [Related]  

  • 57. Congenital disorders of glycosylation type Ia and Ib. Genetic, biochemical and clinical studies.
    Kjaergaard S
    Dan Med Bull; 2004 Nov; 51(4):350-63. PubMed ID: 16009061
    [No Abstract]   [Full Text] [Related]  

  • 58. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.
    Citro V; Cimmaruta C; Liguori L; Viscido G; Cubellis MV; Andreotti G
    PLoS One; 2017; 12(12):e0189629. PubMed ID: 29261720
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.
    Matthijs G; Schollen E; Pirard M; Budarf ML; Van Schaftingen E; Cassiman JJ
    Genomics; 1997 Feb; 40(1):41-7. PubMed ID: 9070917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.